Clinical Trials Browser

Salivary Gland Neoplasms × Dasatinib × Clear all

NCT00859937 2018-04-20

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

Phase 2 Completed

55 enrolled 8 charts

Salivary Gland Neoplasms

NCT00507767 2014-10-01

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

15 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms